Stock Track | Ardent Health Partners Soars 5.28% After-Hours on Strong Q4 Results and Upbeat Guidance

Stock Track

Feb 27, 2025

Ardent Health Partners (ARDT) stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.

The healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.

Highlights from Ardent Health's Q4 2024 results:

Total revenue grew 19.3% year-over-year to $1.61 billion
Net income attributable to Ardent Health was $114.2 million, or $0.81 per diluted share
Adjusted EBITDA increased 213% year-over-year to $183 million

In addition to the strong fourth quarter performance, Ardent Health provided optimistic guidance for the full year 2025, projecting total revenue of $6.2 billion to $6.45 billion and adjusted EBITDA of $575 million to $615 million. The company cited encouraging operating environment tailwinds and durable volume growth as key factors underpinning its upbeat outlook.

Ardent Health's CEO, Marty Bonick, highlighted the company's solid operational performance and the approval of the New Mexico state directed payment program, which contributed to the better-than-expected results in 2024. Bonick also outlined strategic priorities for 2025, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and executing on ambulatory growth opportunities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1161392122"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161392122\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1161392122?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 06:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161392122","market":"hk","top_or_hot":-1,"title":"Stock Track | Ardent Health Partners Soars 5.28% After-Hours on Strong Q4 Results and Upbeat Guidance","media":"Stock Track","content":"<p>Ardent Health Partners (ARDT) stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.</p>\n\n<p>The healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.</p>\n\n<p>Highlights from Ardent Health's Q4 2024 results:\n<ul>\n<li>Total revenue grew 19.3% year-over-year to $1.61 billion</li>\n<li>Net income attributable to Ardent Health was $114.2 million, or $0.81 per diluted share</li>\n<li>Adjusted EBITDA increased 213% year-over-year to $183 million</li>\n</ul>\n</p>\n\n<p>In addition to the strong fourth quarter performance, Ardent Health provided optimistic guidance for the full year 2025, projecting total revenue of $6.2 billion to $6.45 billion and adjusted EBITDA of $575 million to $615 million. The company cited encouraging operating environment tailwinds and durable volume growth as key factors underpinning its upbeat outlook.</p>\n\n<p>Ardent Health's CEO, Marty Bonick, highlighted the company's solid operational performance and the approval of the New Mexico state directed payment program, which contributed to the better-than-expected results in 2024. Bonick also outlined strategic priorities for 2025, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and executing on ambulatory growth opportunities.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Ardent Health Partners Soars 5.28% After-Hours on Strong Q4 Results and Upbeat Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Ardent Health Partners Soars 5.28% After-Hours on Strong Q4 Results and Upbeat Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-27 06:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ardent Health Partners (ARDT) stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.</p>\n\n<p>The healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.</p>\n\n<p>Highlights from Ardent Health's Q4 2024 results:\n<ul>\n<li>Total revenue grew 19.3% year-over-year to $1.61 billion</li>\n<li>Net income attributable to Ardent Health was $114.2 million, or $0.81 per diluted share</li>\n<li>Adjusted EBITDA increased 213% year-over-year to $183 million</li>\n</ul>\n</p>\n\n<p>In addition to the strong fourth quarter performance, Ardent Health provided optimistic guidance for the full year 2025, projecting total revenue of $6.2 billion to $6.45 billion and adjusted EBITDA of $575 million to $615 million. The company cited encouraging operating environment tailwinds and durable volume growth as key factors underpinning its upbeat outlook.</p>\n\n<p>Ardent Health's CEO, Marty Bonick, highlighted the company's solid operational performance and the approval of the New Mexico state directed payment program, which contributed to the better-than-expected results in 2024. Bonick also outlined strategic priorities for 2025, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and executing on ambulatory growth opportunities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARDT","symbol_name":"Ardent Health Partners (2024 New Filing)","start_time":0,"source_url":"","article_id":"1161392122","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161392122","pubTimestamp":1740607376,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Ardent Health Partners  stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.The healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.Total revenue grew 19.3% year-over-year to $1.61 billion. Net income at","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARDT":"Ardent Health Partners (2024 New Filing)"},"translate_title":"股票赛道Ardent Health Partners盘后飙升5.28%，得益于强劲的第四季度业绩和乐观的指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARDT":1},"content_text":"Ardent Health Partners (ARDT) stock soared 5.28% in after-hours trading on Wednesday, following the release of the company's fourth quarter 2024 financial results and upbeat guidance for 2025.\nThe healthcare provider reported better-than-expected fourth quarter earnings and revenue, driven by a 9% increase in adjusted admissions and a 9.5% rise in net patient service revenue per adjusted admission compared to the prior year quarter.\nHighlights from Ardent Health's Q4 2024 results:\n\nTotal revenue grew 19.3% year-over-year to $1.61 billion\nNet income attributable to Ardent Health was $114.2 million, or $0.81 per diluted share\nAdjusted EBITDA increased 213% year-over-year to $183 million\n\nIn addition to the strong fourth quarter performance, Ardent Health provided optimistic guidance for the full year 2025, projecting total revenue of $6.2 billion to $6.45 billion and adjusted EBITDA of $575 million to $615 million. The company cited encouraging operating environment tailwinds and durable volume growth as key factors underpinning its upbeat outlook.\nArdent Health's CEO, Marty Bonick, highlighted the company's solid operational performance and the approval of the New Mexico state directed payment program, which contributed to the better-than-expected results in 2024. Bonick also outlined strategic priorities for 2025, including enhancing supply chain efficiencies, advancing service line optimization initiatives, and executing on ambulatory growth opportunities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}